Cagrilintide + Semaglutide

Name: Cagrilintide + Semaglutide
Brand: Canada Peptides
Price: 125.0 CAD
Availability: InStock

$125.00

$125.00 ~~$181.00~~

Sold out

This batch of Cagrilintide + Semaglutide Peptide Blend has been third party lab tested and verified for quality.

Contents: Cagrilintide (Amylin Analogue) + Semaglutide (GLP-1 Receptor Agonist) Combination
Form: Powder
Purity: 99.3%

TESTED FOR:

PURITY

WEIGHT

STERILITY

ENDOTOXINS(LPS)

Weight - 5mg

5mg 10mg

Product variants

Quantity

Free Reconstitution Solution automatically added to your cart with each order.

This product is Made, Tested & Shipped From Canada.

🚚

Shipping & Delivery

We are committed to delivering fast, reliable, and transparent shipping for all orders. Please review our policy below for details on delivery times, tracking, and what to expect with every purchase.

View Full Shipping Policy

99%+ Purity Guaranteed

COA
Verified+

Trackable Shipping

View full details

Cagrilintide + Semaglutide

Cagrilintide + Semaglutide is a dual-peptide research combination evaluated for interactions between complementary pathways regulating body weight, satiety, and glucose metabolism. Semaglutide is a selective GLP-1 receptor agonist, while Cagrilintide is an amylin analog targeting amylin receptor complexes in appetite-regulatory centers of the CNS. Studies investigate whether co-administration provides enhanced control of energy intake and metabolic balance compared to either agent alone.

Research models emphasize reduction of caloric consumption, improved glycemic parameters, and potential synergistic reductions in body weight through both satiety enhancement and gastric transit modulation.

Overview

Combined treatment paradigms examine effects on visceral adiposity, insulin sensitivity, and cardiometabolic indicators including lipids, inflammatory markers, and liver-related metabolic outcomes. The peptide pairing is further assessed for durability of weight change, adherence to controlled nutritional intake, and translation of CNS signaling modulation to whole-body metabolic stability.

Chemical Makeup

This product contains two synthetic peptide hormones with distinct receptor targets. Due to dual-component structure and manufacturing variability, a single definitive molecular formula is not listed. Analytical identity and purity are batch-verified.

Observed Mass (MS): 711.9 Da
Purity (HPLC): 99.42%
Batch Number: 2025007
Primary Retention Time: 3.48 min
Instrument: LCMS-7800 Series (Calibrated)
Analytical Note: Primary peak confirmed by mass and retention time; trace secondary peak area 0.58%

Research and Clinical Studies

Combination Therapy and Weight Management
Studies indicate greater weight reduction from co-administration compared to either GLP-1 or amylin analogs alone in controlled metabolic settings.

Glycemic Stability and Insulin Sensitivity
Evaluations in type 2 diabetes assess improvement in HbA1c, fasting plasma glucose, and post-meal glucose responses.

Visceral Adiposity and Lipid Profiles
Research monitors changes in abdominal fat burden, triglycerides, and markers of fatty acid metabolism.

Appetite Regulation and Meal Size
Preclinical and early-phase clinical research examines enhanced satiety signaling and decreased caloric intake relative to monotherapy.

Cardiometabolic Risk Factors
Investigations track blood pressure changes, oxidative balance, and reductions in markers associated with metabolic stress.

This investigational peptide combination is intended exclusively for scientific laboratory research by qualified personnel. Not for human or veterinary administration.

References

Friedrichsen M, et al. Dual amylin and GLP-1 receptor agonism for obesity research. Lancet. 2021;398(10295):2164–2176. PMID: 34895744.
https://pubmed.ncbi.nlm.nih.gov/34895744/
Lau J, et al. Extended-action amylin analog and metabolic outcomes. Nature. 2021;597:1–6. PMID: 34497389.
https://pubmed.ncbi.nlm.nih.gov/34497389/
Kushner RF, et al. Semaglutide for weight management: a controlled evaluation. N Engl J Med. 2021;384(11):989–1002. PMID: 33567185.
https://pubmed.ncbi.nlm.nih.gov/33567185/
Müller TD, et al. Gut-brain peptide combination therapies in obesity. Physiol Rev. 2022;102(4):1889–1963. PMID: 35426549.
https://pubmed.ncbi.nlm.nih.gov/35426549/
Arora T, et al. Amylin receptor signaling in feeding behavior regulation. Am J Physiol Gastrointest Liver Physiol. 2019;317(3):G429–G438. PMID: 31226682.
https://pubmed.ncbi.nlm.nih.gov/31226682/
Dicker D, et al. Synergistic metabolic impacts of combination incretin-based agents. Diabetes Obes Metab. 2023;25(4):897–908. PMID: 36352316.
https://pubmed.ncbi.nlm.nih.gov/36352316/
ClinicalTrials.gov Identifier: NCT04871225. Combined incretin and amylin analog therapy in obesity research.
https://clinicaltrials.gov/ct2/show/NCT04871225
ClinicalTrials.gov Identifier: NCT05051579. Dual pathway metabolic intervention in type 2 diabetes.
https://clinicaltrials.gov/ct2/show/NCT05051579

For Research Use Only. Not for human or veterinary use.

Click to view

Page 1

Click to view

Page 1

PERFECTLY CALCULATED
Manufactured in cGMP-compliant facilities.
HUB EFFICIENCY
Trustworthy 3-5 business day delivery service.
ASSISTANT EXPERTS
Peptide specialists assist continuously.

Frequently Asked Questions

Here you'll find answers to common questions.

Contact our support team

Every vial we sell comes from a lab that follows current Good Manufacturing Practices (cGMP). That means each step of production is documented and controlled. Before a batch is released, it’s tested by independent third-party labs for purity, identity, and sterility. Certificates of analysis are available so you can see the exact test results.

Yes. The labs we work with use ISO-certified clean rooms where air quality, equipment, and handling procedures are tightly regulated. Staff are trained to pharmaceutical-grade standards. This ensures the peptides are produced in an environment that minimizes contamination risks.

Peptides in lyophilized (freeze-dried) form are stable at room temperature for transport. Once you receive them, refrigeration is recommended to maintain long-term integrity. We package every order securely to prevent damage and ship promptly, so your vials arrive in optimal condition.

We operate under strict in-house protocols that follow current Good Manufacturing Practices (cGMP). That means our team oversees the entire process from sourcing raw amino acids to the final lyophilized vial. Nothing is outsourced or repackaged. This gives us full control over purity, consistency, and sterility, and it’s why we can stand behind every single vial we ship.

Store them in the refrigerator, away from direct light and heat. If you need to keep them longer, some peptides can be stored frozen. Each vial comes with clear handling instructions so you know the proper conditions for stability.

The strongest proof is transparency. For every peptide, we can provide certificates of analysis, manufacturing documentation, and references to the published scientific research behind it. If you ever have questions, we’ll show you the data rather than ask you to take our word for it.

The difference is transparency. Most sites give you a product name and a price. We provide full batch testing, lab documentation, and direct access to certificates of analysis so you don’t have to guess what you’re getting. When you order from us, you know exactly what’s in the vial, where it was made, and how it was verified.

Cagrilintide + Semaglutide